A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy
Clinical trial NCT06839066 · RECRUITING
Trial details
- NCT number
- NCT06839066
- Sponsor
- Shanghai Henlius Biotech
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-02
- Primary completion
- 2026-11-22
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.